{"id":3673,"date":"2014-01-22T14:13:31","date_gmt":"2014-01-22T14:13:31","guid":{"rendered":"\/?p=3673"},"modified":"2014-01-22T14:13:47","modified_gmt":"2014-01-22T14:13:47","slug":"intellicell-biosciences-inc-otcmktssvfc-revived-on-exuberant-buying","status":"publish","type":"post","link":"\/articles\/intellicell-biosciences-inc-otcmktssvfc-revived-on-exuberant-buying\/","title":{"rendered":"Intellicell Biosciences, Inc. (OTCMKTS:SVFC) Revived on Exuberant Buying"},"content":{"rendered":"

Intellicell Biosciences, Inc. (OTCMKTS:SVFC<\/a>) made a commotion at the end of last week, but showed little indication that this could be more than a one-off event. Now, SVFC<\/a> showed a successful Monday, growing by 131% to $0.0074, on dollar volumes of above $2.13 million. SVFC<\/a> kicked into activity at the beginning of the year, riding a free promotional email from Stock Mister. But the latest peak in buying is not explained by an emailed promotion, though investors’ forums are showing huge optimism that the company may start a run on general momentum. \"SVFC2003_1.png\" <\/p>\n

Now, SVFC<\/a> is rather close to the penny levels, which may add to the upward potential. It is a matter of investor confidence whether the buying will continue with the same exuberance that it had on the first trading day of the shortened week.\"ACTC2003.png\"<\/p>\n

SVFC<\/a> is a rare reminder of a once booming sector on the OTC markets- stem cell companies. Among those tickers, several held cult status, and many newcomers used the trend to add value in a short-termed bonanza. SVFC<\/a> is among the companies that are raising a bit too many red flags, showing the following worrying financials:<\/p>\n